Zylem Biosciences is a preclinical biotechnology startup, pioneering the development of targeted medicines by employing rational design inspired by nature. Our novel platform technology spans a deep pipeline of therapies applicable to diseases and conditions where lipid dysfunction plays a critical role, including cancer, skin disease, and eye disease. Visit our website to find out more.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 1375 W Fulton St, Chicago,illinois 60607,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- zylembio.com
- HQ
- Chicago, Illinois
Zylem Biosciences Questions
Zylem Biosciences's website is zylembio.com
Zylem Biosciences's LinkedIn profile is https://www.linkedin.com/company/zylembio
Zylem Biosciences has
6 employees.
View email and phone details for 6
employees at Zylem Biosciences.
Zylem Biosciences's industry is
Biotechnology Research
Zylem Biosciences's top competitors are
Syenex,
Syntax Bio,
Yobee,
Circ Biosciences,
Varchas Biotechnologies, Inc.,
Dimension Bio,
Grove Biopharma, Inc.,
Reax Biotechnologies,
Alnair Therapeutics,
Nuago Therapeutics.
Zylem Biosciences's categories are Biotechnology Research
Zylem Biosciences's founding year is 2018
